Abstract
In this study, anidulafungin (AFG) showed high in vitro activity against 10 isolates of Aspergillus niger by broth microdilution and disk diffusion methods. The efficacy of AFG at 1, 5 and 10mg/kg was tested against six of the isolates in a murine model of disseminated infection. AFG was able to reduce mortality, showing survival rates of 70–100%, 60–100% and 30–60% in mice treated with AFG at 10, 5 and 1mg/kg, respectively. AFG also showed a dose–response efficacy in reducing tissue burden in kidneys and spleen. A parallel experiment demonstrated that administration of AFG did not reduce serum concentrations of galactomannan in mice. Histopathological studies confirmed the efficacy of AFG.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have